MedPath
HSA Product

SODIUM FLUORIDE F18 INJECTION 10-200 mCi/ml

Product approved by Health Sciences Authority (SG)

Basic Information

SODIUM FLUORIDE F18 INJECTION 10-200 mCi/ml

INJECTION, SOLUTION (RADIOPHARMACEUTICAL)

Regulatory Information

SIN14436P

November 11, 2013

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

May 30, 2025

XV09IX06

Company Information

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

Active Ingredients

sodium fluoride F18

Strength: 10-200mCi/ML

Detailed Information

Contraindications

**CONTRAINDICATIONS** None.

Indication Information

**INDICATION AND USAGE** Sodium Fluoride F18 Injection 10–200mCi/ml is indicated for diagnostic positron emission tomography (PET) imaging of bone to define areas of altered osteogenic activity.

© Copyright 2025. All Rights Reserved by MedPath